Nu-Ranit en es it fr

Nu-Ranit Brand names, Nu-Ranit Analogs

Nu-Ranit Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Nu-Ranit Chemical_Formula


Nu-Ranit RX_link

Nu-Ranit fda sheet

Nu-Ranit FDA

Nu-Ranit msds (material safety sheet)

Nu-Ranit MSDS

Nu-Ranit Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Nu-Ranit Molecular Weight

314.405 g/mol

Nu-Ranit Melting Point

69-70 oC

Nu-Ranit H2O Solubility

24.7 mg/mL

Nu-Ranit State


Nu-Ranit LogP


Nu-Ranit Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Nu-Ranit Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Nu-Ranit Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Nu-Ranit Absorption

Approximately 50% bioavailability orally.

Nu-Ranit side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Nu-Ranit Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Nu-Ranit Organisms Affected

Humans and other mammals